0001831283-23-000018.txt : 20230124
0001831283-23-000018.hdr.sgml : 20230124
20230124161223
ACCESSION NUMBER: 0001831283-23-000018
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20230120
FILED AS OF DATE: 20230124
DATE AS OF CHANGE: 20230124
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Larson Yi
CENTRAL INDEX KEY: 0001785987
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-40947
FILM NUMBER: 23548263
MAIL ADDRESS:
STREET 1: C/O TURNING POINT THERAPEUTICS, INC.
STREET 2: 10628 SCIENCE CENTER DRIVE, STE. 200
CITY: SAN DIEGO
STATE: CA
ZIP: 92121
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: LianBio
CENTRAL INDEX KEY: 0001831283
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
STATE OF INCORPORATION: E9
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 103 CARNEGIE CENTER DRIVE, SUITE 309
CITY: PRINCETON
STATE: NJ
ZIP: 08540
BUSINESS PHONE: (609) 486-2308
MAIL ADDRESS:
STREET 1: 103 CARNEGIE CENTER DRIVE, SUITE 309
CITY: PRINCETON
STATE: NJ
ZIP: 08540
4
1
wf-form4_167459472625760.xml
FORM 4
X0306
4
2023-01-20
0
0001831283
LianBio
LIAN
0001785987
Larson Yi
C/O LIANBIO
103 CARNEGIE CENTER DRIVE, SUITE 309
PRINCETON
NJ
08520
0
1
0
0
Chief Financial Officer
Stock Option (Right to Buy)
2.66
2023-01-20
4
A
0
464099
0
A
2033-01-20
Ordinary Shares
464099.0
464099
D
25% of the shares underlying the option will vest and become exercisable on January 20, 2024; the remainder shall vest and become exercisable in 36 equal monthly installments such that the option shall be fully vested on January 20, 2027, subject to the Reporting Person providing continuous service to the Issuer on each such date.
By: /s/ Angela Chen, Attorney-in-Fact
2023-01-24